The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

The Sputum R/M Test is used to analyze sputum samples for abnormal cells, bacteria, or pathogens to diagnose respiratory conditions.

Provide a sputum sample early in the morning using a sterile container. Follow any specific instructions from your healthcare provider.

Results are typically available within 1 to 3 days after the sample is analyzed in the laboratory.

It helps diagnose respiratory infections, monitor lung conditions, and evaluate the effectiveness of treatments.

A craniotomy may be needed to treat brain tumors, aneurysms, epilepsy, or vascular malformations when other treatments are not effective.